Quince Therapeutics, Inc. (QNCX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 36K | 0 | 0 | 35K | 0 | 16K | 0 | 0 | 0 | 304K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -36K | 0 | 0 | -35K | 0 | -16K | 0 | 0 | 0 | -304K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | - | 94.74% | - | - | - | - | - | - |
| Operating Expenses | 11.08M | 19.35M | 13.43M | 9.86M | 14.86M | 10.09M | 5.86M | 28.19M | 11.22M | 8.04M | 6.09M | 5.58M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.27M | 3.63M | 3.28M | 3.34M | 4.79M | 4.27M | 3.63M | 4.7M | 4.97M | 4.61M | 4.66M | 4.23M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 6.84M | 12.6M | 8.08M | 6.55M | 8.14M | 5.83M | 4.92M | 4.15M | 3.7M | 3.43M | 1.43M | 1.35M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -36K | 1000K | 1000K | -35K | 1000K | 0 | -1000K | 1000K | 1000K | 0 | 0 | 0 |
| Operating Income | -11.11M | -19.35M | -13.43M | -9.89M | -14.86M | -10.11M | -5.86M | -28.19M | -11.22M | -8.34M | -6.09M | -5.58M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 25.21% | -91.44% | -129.06% | 64.9% | -32.45% | -21.17% | 3.79% | -404.87% | 13.41% | -32.03% | 20.03% | 65.65% |
| EBITDA | -11.08M | -19.31M | -13.39M | -9.86M | -14.83M | -10.09M | -5.78M | -28.15M | -11.18M | -8.04M | -6.09M | -5.58M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 25.29% | -91.36% | -131.85% | 64.97% | -32.64% | -25.55% | 5.2% | -404.17% | 13.61% | -28.07% | 19.6% | 65.48% |
| D&A (Non-Cash Add-back) | 36K | 39K | 36K | 35K | 32K | 16K | 86K | 44K | 40K | 304K | 0 | 1K |
| EBIT | -11.11M | -16.24M | -11.36M | -15.98M | -12.93M | -12.45M | -8.55M | -8.84M | -8.67M | -8.84M | -6.09M | -5.58M |
| Net Interest Income | 160K | 227K | 300K | 311K | 406K | 536K | 683K | 823K | 887K | 1.01M | 959K | 805K |
| Interest Income | 160K | 227K | 300K | 311K | 406K | 536K | 683K | 823K | 887K | 1.01M | 959K | 805K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 41.69M | -16.96M | -58K | -6.09M | -125K | -2.34M | 384K | 499K | 100K | -500K | 743K | 698K |
| Pretax Income | 30.57M | -36.31M | -13.49M | -15.98M | -14.98M | -12.45M | -5.48M | -27.69M | -11.12M | -8.84M | -5.35M | -4.89M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -5.34M | 3.15M | -46K | 67K | 47K | 7K | 13K | 36K | 31K | 51K | 0 | 0 |
| Effective Tax Rate % | -17.46% | -8.66% | 0.34% | -0.42% | -0.31% | -0.06% | -0.24% | -0.13% | -0.28% | -0.58% | 0% | 0% |
| Net Income | 35.91M | -39.46M | -13.44M | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 338.94% | -216.73% | -144.76% | 42.12% | -34.81% | -40.07% | -2.63% | -467.52% | 9.02% | -60.72% | 32.45% | 70.5% |
| Net Income (Continuing) | 35.91M | -39.46M | -13.44M | -16.05M | -15.03M | -12.46M | -5.49M | -27.73M | -11.15M | -8.89M | -5.35M | -4.89M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 7.17 | -7.50 | -2.50 | -3.40 | -3.40 | -2.80 | -1.30 | -6.40 | -2.60 | -2.20 | -1.50 | -1.40 |
| EPS Growth % | 310.88% | -167.86% | -92.31% | 46.88% | -30.77% | -27.27% | 13.33% | -357.14% | 23.53% | -37.5% | 34.78% | 72.55% |
| EPS (Basic) | 7.17 | -7.50 | -2.50 | -3.40 | -3.40 | -2.80 | -1.30 | -6.40 | -2.60 | -2.20 | -1.50 | -1.40 |
| Diluted Shares Outstanding | 5.01M | 5.01M | 5.4M | 4.67M | 4.39M | 4.33M | 4.32M | 4.31M | 4.3M | 4.1M | 3.61M | 3.59M |
| Basic Shares Outstanding | 5.01M | 5.01M | 5.4M | 4.67M | 4.39M | 4.33M | 4.32M | 4.31M | 4.3M | 4.1M | 3.61M | 3.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |